Re: Intravesical interleukin-2 in T1 papillary bladder carcinoma: regression of marker lesion in 8 of 10 patients

J Urol. 1999 Nov;162(5):1706.
No abstract available

Publication types

  • Comment
  • Letter

MeSH terms

  • Administration, Intravesical
  • Carcinoma, Papillary / drug therapy*
  • Carcinoma, Papillary / pathology*
  • Humans
  • Interleukin-2 / administration & dosage*
  • Urinary Bladder Neoplasms / drug therapy*
  • Urinary Bladder Neoplasms / pathology*

Substances

  • Interleukin-2